- Presentations
- 4
- Markets
- 1
Yutrepia is a brand of Treprostinil marketed by Liquidia Technologies, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Treprostinil
- Brand owner
- Liquidia Technologies
- Registered in
- United States
- Strengths and forms
- 106 mcg inhalation capsule, 26.5 mcg inhalation capsule, 53 mcg inhalation capsule, 79.5 mcg inhalation capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Yutrepia 106 mcg inhalation capsuleInhalation | Liquidia Technologies | US FDA | Available on request |
| Yutrepia 26.5 mcg inhalation capsuleInhalation | Liquidia Technologies | US FDA | Available on request |
| Yutrepia 53 mcg inhalation capsuleInhalation | Liquidia Technologies | US FDA | Available on request |
| Yutrepia 79.5 mcg inhalation capsuleInhalation | Liquidia Technologies | US FDA | Available on request |
Equivalent brands
Other brands of Treprostinil.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Yutrepia
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.